{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T11:55:50Z","timestamp":1778500550992,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100013995","name":"Sanofi Genzyme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013995","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.nbd.2019.04.015","type":"journal-article","created":{"date-parts":[[2019,4,28]],"date-time":"2019-04-28T18:20:17Z","timestamp":1556475617000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics"],"prefix":"10.1016","volume":"129","author":[{"given":"Lisa M.","family":"Stanek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Bu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamya S.","family":"Shihabuddin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2019.04.015_bb0005","doi-asserted-by":"crossref","first-page":"2917","DOI":"10.1038\/ncomms3917","article-title":"A failure in energy metabolism and antioxidant uptake precede symptoms of Huntington's disease in mice","volume":"4","author":"Acu\u00f1a","year":"2013","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2019.04.015_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/gt.2012.60","article-title":"Heparin-binding correlates with increased efficiency of AAV1- and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction","volume":"20","author":"Arnett","year":"2013","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1002\/mds.26020","article-title":"Huntingtin-lowering strategies in Huntington's disease: antisense oligonucleotides, small RNAs, and gene editing","volume":"29","author":"Aronin","year":"2014","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2019.04.015_bb0020","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1007\/s11064-007-9352-7","article-title":"Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications","volume":"32","author":"Bartzokis","year":"2007","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.nbd.2019.04.015_bb0025","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.cmet.2011.08.016","article-title":"Brain energy metabolism: focus on astrocyte-neuron metabolic cooperation","volume":"14","author":"Belanger","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.nbd.2019.04.015_bb0030","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11758","article-title":"Human glia can both induce and rescue aspects of disease phenotype in Huntington disease","volume":"7","author":"Benraiss","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.nbd.2019.04.015_bb0035","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/mt.2009.17","article-title":"Nonallele-specific silencing of mutant and wild-type huntingtin demonstrates therapeutic efficacy in Huntington's disease mice","volume":"17","author":"Boudreau","year":"2009","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0040","doi-asserted-by":"crossref","first-page":"22480","DOI":"10.1073\/pnas.0911503106","article-title":"Expression of mutant huntingtin in mouse brain astrocytes causes age-dependent neurological symptoms","volume":"106","author":"Bradford","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2019.04.015_bb0045","doi-asserted-by":"crossref","first-page":"10653","DOI":"10.1074\/jbc.M109.083287","article-title":"Mutant huntingtin in glial cells exacerbates neurological symptoms of Huntington disease mice","volume":"285","author":"Bradford","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.nbd.2019.04.015_bb0050","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1089\/hgtb.2015.048","article-title":"Analytical ultracentrifugation as an approach to characterize recombinant adeno-associated viral vectors","volume":"26","author":"Burnham","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.nbd.2019.04.015_bb0055","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/nn.3705","article-title":"Astrocytes go awry in Huntington's disease","volume":"17","author":"Chan","year":"2014","journal-title":"Nat. Neurosci."},{"issue":"12","key":"10.1016\/j.nbd.2019.04.015_bb0060","first-page":"1411","article-title":"A7 drug discovery approach for rare neurological diseases: using novel zinc finger protein technology to develop potential therapy for Huntington's disease","volume":"85","author":"Chiocco","year":"2014","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2019.04.015_bb0065","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ana.410270217","article-title":"Degeneration of pyramidal projection neurons in Huntington's disease cortex","volume":"27","author":"Cudkowicz","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0070","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/mt.2013.289","article-title":"Intrajugular vein delivery of AAV9-RNAi prevents neuropathological changes and weight loss in Huntington's disease mice","volume":"22","author":"Dufour","year":"2014","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0075","doi-asserted-by":"crossref","first-page":"517","DOI":"10.4155\/tde.10.50","article-title":"Viral vectors and delivery strategies for CNS gene therapy","volume":"1","author":"Gray","year":"2010","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.nbd.2019.04.015_bb0080","doi-asserted-by":"crossref","first-page":"16037","DOI":"10.1038\/mtm.2016.37","article-title":"Widespread AAV1- and AAV2-mediated transgene expression in the nonhuman primate brain: implications for Huntington's disease","volume":"3","author":"Hadaczek","year":"2016","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.nbd.2019.04.015_bb0085","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1096\/fasebj.13.9.1099","article-title":"Expression of the Huntington's disease gene is regulated in astrocytes in the arcuate nucleus of the hypothalamus of postpartum rats","volume":"13","author":"Hebb","year":"1999","journal-title":"FASEB J.: Off. Publ. Fed. Am. Soc. Exp. Biol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0090","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1016\/j.neuron.2015.02.026","article-title":"Mutant huntingtin downregulates myelin regulatory factor-mediated myelin gene expression and affects mature oligodendrocytes","volume":"85","author":"Huang","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.04.015_bb0095","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1523\/JNEUROSCI.3693-15.2016","article-title":"Dysfunctional calcium and glutamate signaling in striatal astrocytes from Huntington's disease model mice","volume":"36","author":"Jiang","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2019.04.015_bb0100","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1136\/jnnp.2006.103309","article-title":"Psychiatric disorders in preclinical Huntington's disease","volume":"78","author":"Julien","year":"2007","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"10.1016\/j.nbd.2019.04.015_bb0105","doi-asserted-by":"crossref","first-page":"R53","DOI":"10.1093\/hmg\/ddv442","article-title":"Gene suppression strategies for dominantly inherited neurodegenerative diseases: lessons from Huntington's disease and spinocerebellar ataxia","volume":"25","author":"Keiser","year":"2016","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.04.015_bb0110","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1021\/cn500100r","article-title":"Astrocytes and Huntington's disease","volume":"5","author":"Khakh","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.nbd.2019.04.015_bb0115","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.tins.2017.05.002","article-title":"Unravelling and exploiting astrocyte dysfunction in Huntington's disease","volume":"40","author":"Khakh","year":"2017","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.nbd.2019.04.015_bb0120","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.neuron.2012.05.009","article-title":"Sustained therapeutic reversal of Huntington's disease by transient repression of huntingtin synthesis","volume":"74","author":"Kordasiewicz","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.04.015_bb0125","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1038\/nn1988","article-title":"Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease","volume":"10","author":"Lobsiger","year":"2007","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.04.015_bb0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3233\/JHD-160222","article-title":"Modern genome editing technologies in Huntington's disease research","volume":"6","author":"Malankhanova","year":"2017","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.nbd.2019.04.015_bb0135","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/archneur.58.3.365","article-title":"Glutamate transporters in neurologic disease","volume":"58","author":"Maragakis","year":"2001","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0140","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/hgtb.2013.046","article-title":"Generation and characterization of adeno-associated virus producer cell lines for research and preclinical vector production","volume":"24","author":"Martin","year":"2013","journal-title":"Human Gene Ther. Methods"},{"key":"10.1016\/j.nbd.2019.04.015_bb0145","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1038\/mt.2011.219","article-title":"Preclinical safety of RNAi-mediated HTT suppression in the rhesus macaque as a potential therapy for Huntington's disease. Molecular therapy : the journal of the","volume":"19","author":"McBride","year":"2011","journal-title":"Am. Soc. Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0150","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1016\/j.celrep.2017.08.075","article-title":"The self-inactivating KamiCas9 system for the editing of CNS disease genes","volume":"20","author":"Merienne","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.04.015_bb0155","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/glia.23022","article-title":"Astrocytes are key but indirect contributors to the development of the symptomatology and pathophysiology of Huntington's disease","volume":"64","author":"Meunier","year":"2016","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2019.04.015_bb0160","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/gt.2017.71","article-title":"AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington's disease","volume":"24","author":"Miniarikova","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0165","doi-asserted-by":"crossref","first-page":"13315","DOI":"10.1093\/nar\/gku979","article-title":"Single nucleotide seed modification restores in vivo tolerability of a toxic artificial miRNA sequence in the mouse brain","volume":"42","author":"Monteys","year":"2014","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.nbd.2019.04.015_bb0170","doi-asserted-by":"crossref","first-page":"2418","DOI":"10.1016\/j.ymthe.2018.07.008","article-title":"Extensive transduction and enhanced spread of a modified AAV2 capsid in the non-human primate CNS","volume":"26","author":"Naidoo","year":"2018","journal-title":"Mol. Ther.: J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0175","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3233\/JHD-140092","article-title":"Widespread heterogeneous neuronal loss across the cerebral cortex in Huntington's disease","volume":"3","author":"Nana","year":"2014","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.nbd.2019.04.015_bb0180","doi-asserted-by":"crossref","first-page":"12382","DOI":"10.1128\/JVI.75.24.12382-12392.2001","article-title":"Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector","volume":"75","author":"Passini","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0185","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.nbd.2019.04.015_bb0190","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/brain\/awp006","article-title":"Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin","volume":"132","author":"Pouladi","year":"2009","journal-title":"Brain: J. Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0195","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0896-6273(02)00872-3","article-title":"Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders","volume":"35","author":"Ross","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.nbd.2019.04.015_bb0200","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-4422(10)70245-3","article-title":"Huntington's disease: from molecular pathogenesis to clinical treatment","volume":"10","author":"Ross","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0205","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1083\/jcb.200508072","article-title":"Expression of mutant huntingtin in glial cells contributes to neuronal excitotoxicity","volume":"171","author":"Shin","year":"2005","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0210","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1016\/j.celrep.2018.04.052","article-title":"Integrative characterization of the R6\/2 mouse model of Huntington's disease reveals dysfunctional astrocyte metabolism","volume":"23","author":"Skotte","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.nbd.2019.04.015_bb0215","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/hmg\/ddg169","article-title":"Selective striatal neuronal loss in a YAC128 mouse model of Huntington disease","volume":"12","author":"Slow","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.04.015_bb0220","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3233\/JHD-130057","article-title":"Antisense oligonucleotide-mediated correction of transcriptional dysregulation is correlated with behavioral benefits in the YAC128 mouse model of Huntington's disease","volume":"2","author":"Stanek","year":"2013","journal-title":"J. Huntingt. Dis."},{"key":"10.1016\/j.nbd.2019.04.015_bb0225","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/hum.2013.200","article-title":"Silencing mutant huntingtin by adeno-associated virus-mediated RNA interference ameliorates disease manifestations in the YAC128 mouse model of Huntington's disease","volume":"25","author":"Stanek","year":"2014","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0230","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41434-018-0017-8","article-title":"Rationally designed AAV2 and AAVrh8R capsids provide improved transduction in the retina and brain","volume":"25","author":"Sullivan","year":"2018","journal-title":"Gene Ther."},{"key":"10.1016\/j.nbd.2019.04.015_bb0235","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S1474-4422(10)70276-3","article-title":"Biological and clinical changes in premanifest and early stage Huntington's disease in the TRACK-HD study: the 12-month longitudinal analysis","volume":"10","author":"Tabrizi","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0240","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1038\/nn.3691","article-title":"Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington's disease model mice","volume":"17","author":"Tong","year":"2014","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.nbd.2019.04.015_bb0245","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.1093\/hmg\/ddi407","article-title":"Selective degeneration and nuclear localization of mutant huntingtin in the YAC128 mouse model of Huntington disease","author":"Van Raamsdonk","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.04.015_bb0250","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.nbd.2006.12.010","article-title":"Phenotypic abnormalities in the YAC128 mouse model of Huntington disease are penetrant on multiple genetic backgrounds and modulated by strain","volume":"26","author":"Van Raamsdonk","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.nbd.2019.04.015_bb0255","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/mds.23953","article-title":"Pharmacologic approaches to the treatment of Huntington's disease","volume":"27","author":"Venuto","year":"2012","journal-title":"Mov. Disord.: Off. J. Mov. Disord. Soc."},{"key":"10.1016\/j.nbd.2019.04.015_bb0260","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0265","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1055\/s-2007-971176","article-title":"Huntington's disease","volume":"27","author":"Walker","year":"2007","journal-title":"Semin. Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0270","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1093\/hmg\/ddn175","article-title":"Accumulation of N-terminal mutant huntingtin in mouse and monkey models implicated as a pathogenic mechanism in Huntington's disease","volume":"17","author":"Wang","year":"2008","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.04.015_bb0275","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S1474-4422(17)30280-6","article-title":"Therapies targeting DNA and RNA in Huntington's disease","volume":"16","author":"Wild","year":"2017","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0280","first-page":"487","article-title":"Mutant huntingtin reduction in astrocytes slows disease progression in the BACHD conditional Huntington's disease mouse model","volume":"28","author":"Wood","year":"2018","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2019.04.015_bb2555","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1128\/JVI.72.3.2224-2232.1998","article-title":"Production of high-titer recombinant adeno-associated virusvectors in the absence of helper adenovirus","author":"Xiao","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.nbd.2019.04.015_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2018.03.005","article-title":"A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington's disease","volume":"173","author":"Yan","year":"2018","journal-title":"Cell"}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119301044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996119301044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T05:12:40Z","timestamp":1760850760000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996119301044"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":58,"alternative-id":["S0969996119301044"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2019.04.015","relation":{},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Astrocyte transduction is required for rescue of behavioral phenotypes in the YAC128 mouse model with AAV-RNAi mediated HTT lowering therapeutics","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2019.04.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}